Learn About Blood Clots

What is the definition of Blood Clots?

Blood clots are clumps that occur when blood hardens from a liquid to a solid.

  • A blood clot that forms inside one of your veins or arteries is called a thrombus. A thrombus may also form in your heart.
  • A thrombus that breaks loose and travels from one location in the body to another is called an embolus.

A thrombus or embolus can partly or completely block the flow of blood in a blood vessel.

  • A blockage in an artery may prevent oxygen from reaching the tissues in that area. This is called ischemia. If ischemia is not treated promptly, it can lead to tissue damage or death.
  • A blockage in the vein will often cause fluid buildup and swelling in the area where blood is drained by that vein.
What are the alternative names for Blood Clots?

Clot; Emboli; Thrombi; Thromboembolus; Hypercoagulable state

What are the causes of Blood Clots?

Situations in which a blood clot is more likely to form in veins include:

  • Being on long-term bed rest
  • Sitting for long periods, such as in a plane or car
  • During and after pregnancy
  • Taking birth control pills or estrogen hormones (especially in women who smoke)
  • Long-term use of an intravenous catheter
  • After surgery

Blood clots are also more likely to form after an injury. People with cancer, obesity, and liver or kidney disease are also prone to blood clots.

Smoking also increases the risk of forming blood clots.

Conditions that are passed down through families (inherited) may make you more likely to form abnormal blood clots. Inherited conditions that affect clotting are:

  • Factor V Leiden mutation
  • Prothrombin G20210A mutation

Other rare conditions, such as protein C, protein S, and antithrombin III deficiencies.

A blood clot may block an artery or vein in an organ, affecting the:

  • Heart (angina or a heart attack)
  • Intestines (mesenteric ischemia or mesenteric venous thrombosis)
  • Kidneys (renal vein thrombosis)
  • Leg or arm arteries
  • Legs (deep vein thrombosis)
  • Lungs (pulmonary embolism)
  • Neck or brain (stroke)
Who are the top Blood Clots Local Doctors?
Internal Medicine
Internal Medicine

Upmc Community Medicine Inc

875 N Hermitage Rd, 
Hermitage, PA 
 (11.0 mi)
Languages Spoken:
English
Offers Telehealth

Mark Fantaski is an Internal Medicine provider in Hermitage, Pennsylvania. Dr. Fantaski and is rated as an Experienced provider by MediFind in the treatment of Blood Clots. His top areas of expertise are Disseminated Intravascular Coagulation, Congenital Anti-Plasmin Deficiency, Prekallikrein Deficiency, and Cirrhosis.

Hematology Oncology | Oncology | Hematology
Hematology Oncology | Oncology | Hematology

Oncology Hematology Association Inc

2200 Memorial Dr, 
Farrell, PA 
 (12.1 mi)
Languages Spoken:
English
Accepting New Patients

William Spielvogle is a Hematologist Oncology specialist and an Oncologist in Farrell, Pennsylvania. Dr. Spielvogle and is rated as an Experienced provider by MediFind in the treatment of Blood Clots. His top areas of expertise are Paget Disease of the Breast, Angiosarcoma, Thrombocytopenia, and Lynch Syndrome. Dr. Spielvogle is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Internal Medicine
Internal Medicine

Upmc Community Medicine Inc

3124 Wilmington Rd, Noble House Medical Clinic, 
New Castle, PA 
 (13.7 mi)
Languages Spoken:
English
Offers Telehealth

Elbert Acosta is an Internal Medicine provider in New Castle, Pennsylvania. Dr. Acosta and is rated as an Experienced provider by MediFind in the treatment of Blood Clots. His top areas of expertise are Pulmonary Edema, Heart Failure, Heart Attack, and Chronic Kidney Disease.

What are the latest Blood Clots Clinical Trials?
Post Marketing Surveillance Study for Jivi (Damoctocog Alfa Pegol) in Korean Patients With Hemophilia A

Summary: In this study, researchers will observe and study the data from participants with hemophilia A who receive damoctocog alfa pegol as prescribed by their doctors. Participants will not receive any advice or changes to their healthcare during the study. Hemophilia A is a genetic bleeding disorder. It is caused by the lack of a protein called clotting factor 8 (FVIII) that helps blood to clot properly...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Prospective, One-arm and Open Clinical Study to Assess Safety and Efficacy of Anti-Human CD20 Monoclonal Antibody Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia

Summary: To evaluate the safety and efficacy of Obinutuzumab in the treatment of pediatric primary immune thrombocytopenia in patients who have not responded adequately or relapsed after first-line glucocorticoid treatment.

Who are the sources who wrote this article ?

Published Date: June 17, 2024
Published By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Anderson JA, Weitz JI. Hypercoagulable states. In: Hoffman R, Benz EJ, Silberstein LE, et al, eds. Hematology: Basic Principles and Practice. 8th ed. Philadelphia, PA: Elsevier; 2023:chap 138.

Cross SS. Ischaemia, infarction and shock . In: Cross SS, ed. Underwood's Pathology. 7th ed. Philadelphia, PA: Elsevier; 2019:chap 7.

Schafer AI. Approach to the patient with bleeding or thrombosis: hypercoagulable states. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 157.